TruthArchive.ai - Related Video Feed

Speaker 0 asks: first, what impacts the loss of bifidobacterium? and second, what can we do to replenish it and keep it strong and populated? Speaker 1 responds that the microbiome is still in its infancy, and urges not to assume you can test your stools in the market because the FDA doesn’t have a test approved for testing stool. Regarding buying Bifidobacterium, he says that the problem with replenishing is you may suppress your own ability to make Bifidobacteria, and what Bifidobacteria needs is good nutrition, good vitamins, and good yogurt. He cites the case of a woman who lived to 117 years old in India, noting that remnants of bifidobacteria were found in her stools, and that she ate yogurt three times a day. When asked how much she ate, he replies that there aren’t studies on that, but yogurt is happening. Speaker 1 continues: in a world where we constantly dodge viruses, parasites, and bacteria that secrete toxins, survival involves doing one’s best. There are things that kill the microbiome, notably antibiotics. Therefore, when you take antibiotics, that’s the time to supplement with a good probiotic and good vitamins. He notes a problem: 16 out of 17 probiotics on the market do not have Bifidobacteria. He explains why he began focusing on Bifidobacteria: in the trillion-dollar probiotic industry, if you turn a bottle around and read the ingredients, the bacteria listed are Bifidobacteria. That observation during the pandemic sparked his interest in Bifidobacteria. He says the whole path is to save the Biff, referencing the idea that during stressful moments—political division, hate, anger—seeing the power of a microbe becomes important.

We need studies where people test their stools to see if long-term vitamin C improves bifidobacteria. To advance microbiome research, protocols need to be done properly. A clinician cannot recommend different vitamin C products from different stores because of variations in supervision. Selling a specific product ensures consistency, avoiding comparisons between different vitamins. Advancing this research is challenging because natural substances like vitamin C, vitamin D, and naturally occurring microbes cannot be patented. Patenting requires fabricating or modifying something to be new and novel. The speaker realized that forces are trying to stop innovations, despite a clinician's role to help patients with informed consent.

While treating COVID patients with hydroxychloroquine, the speaker discovered ivermectin's effect on oxygen saturation. This led to the realization that ivermectin is in the same phylum as bifidobacteria, which were found to be lacking in severe COVID cases. Antibiotics are essentially microbes, illustrated by the discovery of penicillin from apple mold killing bacilli. Similarly, vaccines are microbes or pieces of microbes. The speaker notes that drugs are made somehow. Ivermectin is the fermented product of a soil bacteria. The speaker poses the question of whether ivermectin's secretion feeds bifidobacteria, potentially boosting immunity, while emphasizing that this is still under research.

The speaker, a gastroenterologist, discusses research on the microbiome's role in COVID-19 and challenges faced publishing findings that went against the public health narrative. Early research documented the virus in stools for up to 45 days and showed hydroxychloroquine and azithromycin killed COVID-19 in stools, but also harmed the microbiome, necessitating vitamin C, D, and zinc. The FDA initially granted an exemption for clinical trials using this combination, then revoked it. Media-fueled fear around hydroxychloroquine hindered recruitment. Research revealed that severe COVID-19 patients lacked bifidobacteria, a key microbe for immunity, which is abundant in newborns but declines with age. Vitamin C and ivermectin were found to increase bifidobacteria. A hypothesis that ivermectin increased bifidobacteria was retracted after being widely read. Research on mRNA vaccines showed they killed bifidobacteria, presented at a gastroenterology conference, linking bifidobacteria loss to Crohn's disease, Lyme disease, and invasive cancer. The speaker concludes that research interference during the pandemic hindered scientific progress and that clinical trial guidelines were not followed.

Speaker explains the intent to guide toward nutrients that increase bifidobacteria: "vitamin C increases bifidobacteria, vitamin D increases bifidobacteria, bovine immunoglobulins, ... increases bifidobacteria." Probiotics based on bifidobacteria were shown in newborns and "decrease with old in old people." He warns, "majority of probiotics out there say they have bifidobacteria but don't even have bifidobacteria," and that even when present, "it's not making it all the way to the large intestine" because "it gets broken down by the stomach acids" or "small bowel, which now causes SIBO." If a patient has some bifidobacteria, he uses vitamins to increase it; if not, "I will give a probiotic," but "the probiotic you have to make sure the probiotic is quality. You have to make sure it goes to the colon." Overuse can cause gas, bloating, and SIBO. Baseline testing is essential: "You have to test it ... know where you are at baseline," not using unvalidated labs. They rely on a validated assay and fecal transplant data; if a patient had "4% Bifidobacteria" and the probiotic raises it to "5%", but if it drops to "zero," "we have a problem," akin to antibiotics.

remember, I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant. The first thing that came to me during COVID was I bet you it's in the stools. COVID can persist in the stools. Some people were asymptomatic and had COVID in their stools, but yet never had symptoms. What was the difference between those people? The difference was their bifidobacteria. Forty three severe patients with COVID had zero Bifidobacteria. Bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID. Anecdotal studies like of kimchi and sauerkraut because obviously you can talk to people that ate sauerkraut and still got COVID.

Speaker discusses anecdotal findings on bifidobacteria from vitamin C and ivermectin, and the publish‑or‑perish obstacle in research. "I took a lot of vitamin c at the beginning of the pandemic. Grams a day." "I do not recommend it to anybody." He did it as a guinea pig, and notes that vitamin C "increases bifidobacteria." He then tested about 20 patients to see what happened. "Ivermectin increases bifidobacteria," but publication was blocked by research interference, making long-term effects unclear—"could there be kidney problems? Could there be liver problems?" He laments that you cannot advance research if you don't publish, because publication validates work. When he published "the lost microbes of COVID," labs, Japan, China, and Italy, reproduced the data, confirming replication. "If that paper is real, it gets reproduced into three, four, five papers." He emphasizes colonization as the essence of the work and notes cross‑population questions about who it helps.

" I'm a big believer of vitamin c. " "This doesn't mean it's going to work for everyone and we're not making any claims. " "There is definitely something about vitamin C through the years that have said to people, wait, vitamin C is pretty safe. " "But then we looked at the in vitro studies and that's how they grow the bitter bacteria. " "In vitro studies of vitamin C effect on the microbiome, you actually see increased Bifidobacteria with in vitro. " "So we just proved on a human clinical model what the in vitro model did. " "I'm on this big push of increasing the betrobacteria. " "That's my science... my vision. " "Are antibiotics good? Are they good long term? " "Now we're in the world of biologics. What are biologics doing to the microbiome? " "Maybe all disease starts with lots of bifidobacteria. " "As I'm improving the benefit of bacteria, I see improvement in the disease clinically as a physician."

Observation: in hypoxic patients, bifidobacteria rise after ivermectin, suggesting a mechanism. With COVID, loss of bifidobacteria is seen in severe or recurrent cases; ivermectin appears to feed bifidobacteria, and oxygen levels improve. 'Crashing oxygen is a huge part of the danger of COVID.' Hypothesis: viruses travel from nose to blood to gut; a study found COVID in the gut, in stool. If COVID is in the gut and ivermectin increases bifidobacteria, the bifidobacteria may take on cytokines, flushing them out, freeing room in the colon to grab cytokines from the body. Cytokine storm—'it's a secretion that basically causes you to have anaphylactic reaction.' Increasing bifidobacteria may liberate cytokines, leading to diarrhea, which is removing the virus from your system. Vitamin C or D or ivermectin associated with diarrhea. The colon evacuates toxins. Data was accurate when I published it. It was retracted after I published it.

The speaker observed that patients with severe COVID were missing bifidobacteria compared to those highly exposed but uninfected. Bifidobacteria is a key microbe for immunity and is present in newborns but absent in older people. The speaker's research indicated vitamin C increases bifidobacteria, which may explain its use for treating colds. Ivermectin also increased bifidobacteria within 24 hours, possibly because it's a fermented product of a similar bacteria. The speaker hypothesized that ivermectin's observed benefits in COVID patients might be due to increased bifidobacteria. This hypothesis was the most read during the pandemic but was later retracted. The speaker believes the retraction of a hypothesis is not in the spirit of science.

The speaker, a gastroenterologist, discusses their research on the microbiome and COVID-19. They found that the virus lingers in stools, hydroxychloroquine kills the virus but harms the microbiome, and bifidobacteria is crucial for immunity. Their studies on vitamin C, ivermectin, and mRNA vaccines' effects on bifidobacteria faced challenges in publication due to going against the mainstream narrative. They highlight the importance of unbiased research and collaboration in finding solutions. The speaker also raises concerns about pharmaceutical companies prioritizing profits over patient safety during the pandemic.

The speaker describes microbiome work on COVID-19 and post-mRNA vaccination, noting profound microbiome effects. “I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant.” During COVID, “I bet you it's in the stools.” They found “COVID in the stools in a hundred percent of patients that were positive nasal swab” and that “COVID can persist in the stools.” Some asymptomatic individuals had COVID in stools; “the difference was their bifidobacteria.” Early anecdotal signals about kimchi and sauerkraut are discussed: “What's different between that population? Why is one person eating sauerkraut and kimchi is fine and another person not?” They observed that “forty three severe patients with COVID had zero Bifidobacteria.” They say they will “focus on Bifidobacteria, not the others, because there are some people that have zero bifidobacteria and never got COVID... create a resilience.” Finally, “So bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID.”

"When fecal transplant showed more than, you know, improving C." "And one of my patients with Alzheimer's started remembering his daughter's date of birth, I said, what did I do? I just changed the microbiome." "I used the wife's microbiome to the husband." "It wasn't about pushing stools for Alzheimer's, but what was causing Alzheimer's? What microbes was the culprit?" "What microbes could suppress that microbe That's the culprit." "Babies have a lot of bifidobacteria, this important microbe that helps us decompose sugar." "And we saw a lot of Bifidobacteria in newborns." "There is obviously a consensus in the medical field because there's a lot of gynecologists now that are using the secretions from the vagina of the mom and smearing it on the baby that is born with C section to just make them healthier in a way."

I discovered that patients with severe COVID lacked a key bacteria, bifidobacteria, which is crucial for immunity. Newborns have this bacteria, while the elderly do not due to aging. Vitamin C and Ivermectin were found to increase bifidobacteria levels. I published a hypothesis linking Ivermectin to bifidobacteria increase, which gained attention but was retracted. Hypotheses are essential in science.

Speaker 0: I had been on the front line in Miami, and my go-to is always vitamin C. Speaker 1: Do you take it orally or is that— Speaker 0: just Orly. Orly. Speaker 1: Orly. Is there a certain amount that you can take orally? Speaker 0: Well, I was taking a lot because I was exposed and I was worried. But then what I realized was I tested my sample, my scientist calls me and he goes, Did you notice your C? Did you notice your Bifidobacteria went up four times the level? What have you been doing? I go, Oh, I’ve been taking high dosages of vitamin C. And then he said to me, Well, you got to look into vitamin C. So right away, I switched my gears. As I’m dealing with treating COVID patients, as I’m dealing at looking at the stools before in high risk and severe, I switched my gears and I said, Okay, we need to call a bunch of naturopaths and send us patients before and after. So I started making phone calls again and said, I’ll pay for stool samples before and after on patients with vitamin C. And then we had like twenty, twenty five samples, and we noticed that the vitamin C increased Bifidobacteria. We published on that because actually vitamin C increases Bifidobacteria in vitro. So we published the paper to show that it increased in patients.

"Vitamin C improves gut Bifidobacteria in humans." "This was an incidental finding of my berythrombacteria increasing with vitamin C." "the only thing I've done different is I've been taking these enormous amounts of vitamin c." "Essentially, what we noticed was an increase in the bifidobacteria." "within twenty four hours of the infusion of the pills." "We created the Microbiome Research Foundation essentially to raise the funds to continue doing the research." "So when the vitamin C came on, it was really calling my colleagues and saying, have a protocol that is looking at the microbiome." "Our job was not to treat the kids." "We gave an informed consent." "we didn't need an IRB approved giving vitamin c to these kids." "We got these kids poop." "Our job was to look at what is vitamin c doing before and after." "before and after for nutraceuticals, pre and post vaccination, pre and post drugs, pre and post foods." "We tested 20 kids."

The speaker discusses personal experiences with their microbiome and the role of vitamin C in recovering gut bacteria after a disruption. They note that when they killed their microbiome, they had zero, and then saw a reappearance of bacteria with vitamin C. They raise questions about whether remnants or precursor forms of bifidobacteria were missed by testing, and whether there are unknown factors from the microbiome that weren’t captured. They describe this as a future area of study: determining how much vitamin C to administer, for how long, and whether to use it short-term or long-term. The speaker shares their own recovery process after wiping out their microbiome, mentioning that it took a long time and involved tracking bifidobacteria until it stabilized. Once stability was achieved, they felt back to normal and stopped using supplements, returning to their pre-pandemic routine. They describe this as “refloralization,” a term they coined to describe bringing back the flora and microbes to resemble what they were before, acknowledging that no one has their exact pre-pandemic microbiome signature. They express hope that future efforts—ideally in collaboration with a government agency—will make stool assays available to the public so long-haulers can understand their gut health, including the status of bifidobacteria and how dietary factors might affect it. The speaker emphasizes that addressing long-hauler symptoms requires attention to bifidobacteria in the gut and understanding which foods promote or diminish it, including which meats are beneficial or not. They acknowledge that giving practical hints is complex because many factors influence bifidobacteria. They illustrate this with an analogy: a personal conflict the night before could reduce bifidobacteria, underscoring how daily events can impact gut health. The speaker also notes personal changes in temperament, describing themselves as previously a fireball who would engage in conflicts, but who has become calmer as stress responses shift, particularly in light of stressful news or retracted papers. They conclude with a sense of resilience, joking about not being overly affected by setbacks and maintaining confidence in their ongoing adaptation.

In December 2020, the speaker began collecting stool samples from colleagues before and after their COVID vaccination to study the vaccine's impact on the microbiome. The speaker discovered that mRNA vaccines killed bifidobacteria but believed these findings were unpublishable due to the prevailing narrative. The speaker presented this research as an abstract at the American College of Gastroenterology in October 2022, where it won a research award, beating 6,000 other abstracts. This abstract drew the attention of 18,000 GI doctors, who began to consider that the loss of bifidobacteria may explain why they contracted COVID after vaccination. Further research indicated persistent damage to bifidobacteria from the vaccine. The speaker's presentation also linked the loss of bifidobacteria to Crohn's disease, Lyme disease, and invasive cancer.

Speaker 0 and Speaker 1 describe findings from studying COVID and the gut microbiome, focusing on bifidobacteria. They state that their lab was the one to detect COVID in stool samples. Their central questions were what COVID does to the microbiome and how long the virus remains in the gut. They observed that one patient had COVID for up to 45 days after respiratory symptoms resolved, and another case showed the virus detectable for up to a year and a half after respiratory symptoms ended. This led them to investigate differences between people who do and do not get COVID, including households with similar exposures. A key observation was linked to bifidobacteria. They note that a difference between individuals who stayed healthy and those who contracted COVID was the level of bifidobacteria. They point out that bifidobacteria are the bacteria commonly advertised as probiotics, present in newborns and that aging is associated with its decline. They emphasize bifidobacteria as an important microbe for the microbiome and its potential role in health outcomes. The discussion includes an example: a farmer who kissed his COVID-positive wife and did not get COVID himself had high microbial diversity and a good amount of bifidobacteria, suggesting resilience due to microbial composition, including bifidobacteria. They extend the implication to mental health, noting that loss of bifidobacteria has been observed in anxiety and bipolar disorder, while acknowledging this is not the only microbe involved in those conditions. Another function attributed to bifidobacteria is aiding digestion: they help break down food to release sugars that enter cells, and assist in releasing calcium. The speakers contrast this with the broader focus on mitochondria and mitochondrial function, arguing that gut microbes initiate the process by breaking down food in the bowels to supply sugars and calcium for cellular processes. In summary, their findings indicate that people with higher bifidobacteria are more resilient to COVID and healthier, whereas those with lower bifidobacteria correlate with greater vulnerability; bifidobacteria play a role in sugar absorption, calcium release, and overall metabolic and potentially mental health outcomes. Speaker 1 and Speaker 0 confirm: people with more bifidobacteria were more resilient and did not get sick from COVID, while those who got very sick did not have enough bifidobacteria or had low levels.

Bifidobacteria is presented as a common denominator lacking in individuals with autism, Alzheimer's, cancer, anxiety, bipolar disorder, obesity, and diabetes. The speaker questioned why young people were less affected by COVID-19 compared to older, diabetic, or obese individuals, and also why some seemingly healthy individuals with autoimmune conditions were severely affected. The speaker had pre-pandemic microbiome data and observed a correlation between bifidobacteria levels and COVID-19 outcomes. High-risk individuals exposed to COVID-19 who never contracted the virus had high levels of bifidobacteria, while those who contracted the virus multiple times had zero bifidobacteria. This observation reinforced the importance of bifidobacteria, further emphasized by treatment outcomes.

During the pandemic, the speaker took 1,000-3,000mg of Vitamin C but currently takes none due to a balanced microbiome. Testing confirms good bifidobacteria levels, especially during summer with outdoor microbe exposure. Vitamin D from the sun also boosts bifidobacteria. Vitamin C intake may need to increase depending on location. As people age, skin produces less Vitamin D, making Vitamin D and K2 the most important vitamins for older individuals.

- "Who knew bifidobacteria liked vitamin c and liked vitamin d and that it grew?" - "We saw an in vitro study, but nobody's ever done a clinical study where you give people vitamin C until our lab where we basically took 20 patients and we gave them vitamin C before and after and noticed vitamin C increases bifidobacteria." - "Now it's like that light bulb, right?" - "That comes out that says, wait a minute, a patient has COVID, he has lots of bifidobacteria because he has COVID or a virus, right? Any virus." - "And is this why vitamin C is helping with viruses?" - "Because it increases the bifidobacteria that those people are lacking to begin with, right?" - "So are these microbes depleted in nutrients and what nutrient feeds each microbe?" - "This is the future. So it's gonna change nutrition a lot."

Speaker 0: Bifidobacteria was absent in kids with autism, that Bifidobacteria was absent in Alzheimer's. Bifidobacteria was absent in long haulers, vaccine injured, Lyme patients, Crohn's patients, invasive cancer. When you look at who has Bifidobacteria, the newborns have a lot of Bifidobacteria, old people have zero Bifidobacteria. Nursing home dying, zero Bifidobacteria. The process of aging is really this loss of Bifidobacteria. Expanded: if you look at and you believe the Bible, you know, people lived a lot longer. In biblical times than we are right now. We're barely making it to seventy, eighty and not really healthy seventy, eighty. You know, the mind starts going. So, is the mind starting to go because of the loss of Bifidobacteria? And, when you start looking at, well, what improves Bifidobacteria, right? So, our lab discovered vitamin C improves Bifidobacteria. Okay. Our lab discovered bovine immunoglobulins, the blood of the cow spun around that clear stuff, provided that the cow is not on a lot of antibiotics, is not given a lot of hormones, is not given like thousands of vaccines. So when you start looking at all that, you start seeing the importance of Bifidobacteria and you start seeing, like even me, you know, with Progena Biome, looking at the stool samples before the pandemic, during the pandemic and after the pandemic, there is a lot of disappearance of Bifidobacteria. Is that why we're having an increase in Alzheimer's, increase in cancer? Have we demolished this bifidobacteria? So, to me, that's a very important microbe that I believe is our longevity, if we can retain it. And it's not easy to retain in a world that's toxic in a way and in a world where we are, you know, put you know, given media full of stress, where we are divided, where we are, you know, constantly nervous of the next pandemic or the next virus, you know, it's it's almost like this bottle that you're shaking and it's full of gas and you just need to put it on the counter and let it just calm down, right? So, I think that's, it's a very important microbe.

The speaker, a gastroenterologist, discusses research on the microbiome's role in COVID-19 and challenges encountered publishing findings that contradicted the public health narrative. Early research identified the full viral sequence in stool samples, where it lingered for up to 45 days, and noted hydroxychloroquine and azithromycin killed the virus in stools but harmed the microbiome, leading to the addition of vitamins C, D, and zinc to treatment protocols. An initial FDA exemption for clinical trials using this combination was revoked, and media-fueled fear around hydroxychloroquine hindered recruitment. Research revealed that patients with severe COVID-19 lacked bifidobacteria, a key microbe for immunity, which is abundant in newborns but decreases with age. Vitamin C and ivermectin were found to increase bifidobacteria levels. A hypothesis that ivermectin increased bifidobacteria was retracted after being widely read. Research on mRNA vaccines showed they killed bifidobacteria, a finding presented at a gastroenterology conference and linked to conditions like Crohn's disease, Lyme disease, and invasive cancer. The speaker concludes that interference with research during the pandemic hindered scientific progress and that established clinical trial guidelines were not followed.

The speaker investigated a commercially available microbe, typically given to infants in small doses. To increase the dosage, they created a yogurt-like substance to amplify the bacterial counts a thousandfold. The speaker observed effects in the mice they studied. Surprisingly, the speaker claims that every observation seen in mice has also been observed in humans.